Home » Stocks » Centogene

Centogene N.V. (CNTG)

Stock Price: $13.30 USD -3.77 (-22.09%)
Updated Jul 10, 2020 4:00 PM EDT - Market closed
After-hours: $13.39 +0.09 (0.68%) Jul 10, 7:53 PM

Stock Price Chart

Key Info

Market Cap 264.16M
Revenue (ttm) 54.81M
Net Income (ttm) -23.21M
Shares Out 19.86M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 10, 2020
Last Price $13.30
Previous Close $17.07
Change ($) -3.77
Change (%) -22.09%
Day's Open 13.75
Day's Range 13.20 - 13.92
Day's Volume 2,248,162
52-Week Range 7.80 - 28.71

More Stats

Market Cap 264.16M
Enterprise Value 248.28M
Earnings Date (est) Apr 29, 2021
Ex-Dividend Date n/a
Shares Outstanding 19.86M
Float 3.44M
EPS (basic) n/a
EPS (diluted) n/a
FCF / Share 0.75
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 5.63%
Payout Ratio n/a
Shares Short 94,467
Short Ratio 2.62
Short % of Float 0.71%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio 17.77
PS Ratio 4.82
PB Ratio 7.96
Revenue 54.81M
Operating Income -20.99M
Net Income -23.21M
Free Cash Flow 14.86M
Net Cash 15.87M
Net Cash / Share 0.80
Gross Margin 46.69%
Operating Margin -38.30%
Profit Margin -42.30%
FCF Margin 27.12%
ROA -15.02%
ROE -62.25%
ROIC -32.30%
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 2
Overweight 1
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$22.50*
(69.17% upside)
Low
21.0
Current: 13.30
High
25.0
Target: 22.50
*Average 12-month USD price target from 4 stock analysts.

Financial Performance

Financial numbers in millions EUR.

Financial Overview

Year2019201820172016
Revenue48.7840.4831.6927.67
Revenue Growth20.51%27.74%14.53%-
Gross Profit22.7820.5416.7514.81
Operating Income-18.68-10.61-4.46-4.94
Net Income-20.66-10.97-5.35-5.22
Shares Outstanding19.8619.86--
Earnings Per Share-1.30-0.80-0.40-25.00
Operating Cash Flow-7.78-4.58-4.341.39
Capital Expenditures21.00-8.71-15.50-7.74
Free Cash Flow13.23-13.29-19.84-6.35
Cash & Equivalents41.109.223.160.00
Total Debt26.9719.6819.34-
Net Cash / Debt14.13-10.46-16.180.00
Assets11876.6755.49-
Liabilities57.6549.3938.75-
Book Value59.8627.2816.74-
Numbers in millions EUR, except per-share numbers.

Company Profile

Company Details

Full Name Centogene N.V.
Country Germany
Employees 440
CEO Arndt Rolfs

Stock Information

Ticker Symbol CNTG
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: CNTG

Description

Centogene N.V. operates as a commercial-stage rare disease company in Europe, Middle East, North America, Latin America, and Asia Pacific. The company operates through two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment offers various services, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. The Diagnostics segment provides genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. It focuses on transforming clinical and genetic data into medical solutions for patients, physicians, and pharmaceutical companies. The company develops rare disease platform based on data repository, which includes epidemiologic, phenotypic, and genetic data that enhances methods for identifying and monitoring rare hereditary diseases and provide solutions that accelerate the development of orphan drugs. The company has collaborative research agreement with Shire related for HAE Kininogen assay mass spectrometry testing and screening. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.